+ USFDA Permits Ranbaxy to Produce And Sell Generic Atrovastitin in US Market Sprightly Spirit, News, 0 The United States Food And Drug Administration (USFDA) has accorded permission to Ranbaxy Laboratories to produce “Atrovastitin” – the...